105 related articles for article (PubMed ID: 11693538)
21. Anti-angiogenic activity of torilin, a sesquiterpene compound isolated from Torilis japonica.
Kim MS; Lee YM; Moon EJ; Kim SE; Lee JJ; Kim KW
Int J Cancer; 2000 Jul; 87(2):269-75. PubMed ID: 10861486
[TBL] [Abstract][Full Text] [Related]
22. K20E, an oxidative-coupling compound of methyl caffeate, exhibits anti-angiogenic activities through down-regulations of VEGF and VEGF receptor-2.
Pan CH; Lin WH; Chien YC; Liu FC; Sheu MJ; Kuo YH; Wu CH
Toxicol Appl Pharmacol; 2015 Jan; 282(2):215-26. PubMed ID: 25481497
[TBL] [Abstract][Full Text] [Related]
23. Anti-angiogenic effect of Biophytum sensitivum is exerted through its cytokine modulation activity and inhibitory activity against VEGF mRNA expression, endothelial cell migration and capillary tube formation.
Guruvayoorappan C; Kuttan G
J Exp Ther Oncol; 2007; 6(3):241-50. PubMed ID: 17552364
[TBL] [Abstract][Full Text] [Related]
24. [Anti-angiogenic effect of vinorelbine in combination with cetuximab in vitro and in vivo].
Qian XP; Liu BR; Wan L; Hu J; Zhu LJ; Yu LX
Zhonghua Zhong Liu Za Zhi; 2010 Apr; 32(4):253-7. PubMed ID: 20510073
[TBL] [Abstract][Full Text] [Related]
25. ZLM-7 exhibits anti-angiogenic effects via impaired endothelial cell function and blockade of VEGF/VEGFR-2 signaling.
Su M; Huang J; Li J; Qin X; Tang X; Jin F; Chen S; Jiang C; Zou Z; Peng K; Nuruzzaman M; Zhang J; Luo J; Liu S; Luo Z
Oncotarget; 2016 Apr; 7(14):19018-30. PubMed ID: 26967559
[TBL] [Abstract][Full Text] [Related]
26. Rosmarinic acid inhibits angiogenesis and its mechanism of action in vitro.
Huang SS; Zheng RL
Cancer Lett; 2006 Aug; 239(2):271-80. PubMed ID: 16239062
[TBL] [Abstract][Full Text] [Related]
27. Total alkaloids of Rubus alceifolius Poir shows anti-angiogenic activity in vivo and in vitro.
Zhao J; Lin W; Zhuang Q; Zhong X; Cao Z; Hong Z; Peng J
Integr Cancer Ther; 2014 Nov; 13(6):520-8. PubMed ID: 25148840
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of angiogenic differentiation of human umbilical vein endothelial cells by diallyl disulfide (DADS).
Thejass P; Kuttan G
Life Sci; 2007 Jan; 80(6):515-21. PubMed ID: 17196623
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis and characterization of potent microtubule inhibitors with dual anti-proliferative and anti-angiogenic activities.
Zhang H; Fang X; Meng Q; Mao Y; Xu Y; Fan T; An J; Huang Z
Eur J Med Chem; 2018 Sep; 157():380-396. PubMed ID: 30099258
[TBL] [Abstract][Full Text] [Related]
30. N-/C-terminal deleted mutant of human endostatin efficiently acts as an anti-angiogenic and anti-tumorigenic agent.
Cho H; Kim WJ; Lee YM; Kim YM; Kwon YG; Park YS; Choi EY; Kim KW
Oncol Rep; 2004 Jan; 11(1):191-5. PubMed ID: 14654925
[TBL] [Abstract][Full Text] [Related]
31. Anti-invasive and anti-angiogenic activities of naturally occurring dibenzodiazepine BU-4664L and its derivatives.
Miyanaga S; Sakurai H; Saiki I; Onaka H; Igarashi Y
Bioorg Med Chem Lett; 2010 Feb; 20(3):963-5. PubMed ID: 20056543
[TBL] [Abstract][Full Text] [Related]
32. RNA damage and inhibition of neoplastic endothelial cell growth: effects of human and amphibian ribonucleases.
Newton DL; Kaur G; Rhim JS; Sausville EA; Rybak SM
Radiat Res; 2001 Jan; 155(1 Pt 2):171-174. PubMed ID: 11121230
[TBL] [Abstract][Full Text] [Related]
33. Anti-angiogenic activity of a new andrographolide derivative in zebrafish and HUVECs.
Li J; Peng Y; Li S; Sun Y; Chan JY; Cui G; Wang D; Zhou GC; Lee SM
Eur J Pharmacol; 2016 Oct; 789():344-353. PubMed ID: 27471159
[TBL] [Abstract][Full Text] [Related]
34. Anti-angiogenic effect of Nelumbo nucifera leaf extracts in human umbilical vein endothelial cells with antioxidant potential.
Lee JS; Shukla S; Kim JA; Kim M
PLoS One; 2015; 10(2):e0118552. PubMed ID: 25714482
[TBL] [Abstract][Full Text] [Related]
35. Diallyl trisulfide inhibits migration, invasion and angiogenesis of human colon cancer HT-29 cells and umbilical vein endothelial cells, and suppresses murine xenograft tumour growth.
Lai KC; Hsu SC; Yang JS; Yu CC; Lein JC; Chung JG
J Cell Mol Med; 2015 Feb; 19(2):474-84. PubMed ID: 25403643
[TBL] [Abstract][Full Text] [Related]
36. Anti-angiogenic effect of auranofin on HUVECs in vitro and zebrafish in vivo.
He MF; Gao XP; Li SC; He ZH; Chen N; Wang YB; She JX
Eur J Pharmacol; 2014 Oct; 740():240-7. PubMed ID: 25064343
[TBL] [Abstract][Full Text] [Related]
37. Erxian decoction, a traditional chinese herbal formula, inhibits angiogenesis in human umbilical vein endothelial cells.
Yu X; Tong Y; Huang W; Ge W
Biol Pharm Bull; 2013; 36(5):754-63. PubMed ID: 23391996
[TBL] [Abstract][Full Text] [Related]
38. Vascular disrupting activity of combretastatin analogues.
Porcù E; Salvador A; Primac I; Mitola S; Ronca R; Ravelli C; Bortolozzi R; Vedaldi D; Romagnoli R; Basso G; Viola G
Vascul Pharmacol; 2016 Aug; 83():78-89. PubMed ID: 27235861
[TBL] [Abstract][Full Text] [Related]
39. Luminacins: a family of capillary tube formation inhibitors from Streptomyces sp. II. Biological activities.
Wakabayashi T; Kageyama-Kawase R; Naruse N; Funahashi Y; Yoshimatsu K
J Antibiot (Tokyo); 2000 Jun; 53(6):591-6. PubMed ID: 10966074
[TBL] [Abstract][Full Text] [Related]
40. Naringenin exerts anti-angiogenic effects in human endothelial cells: Involvement of ERRα/VEGF/KDR signaling pathway.
Li Q; Wang Y; Zhang L; Chen L; Du Y; Ye T; Shi X
Fitoterapia; 2016 Jun; 111():78-86. PubMed ID: 27105956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
